Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Botulinum neurotoxin serotype A inhibited ocular angiogenesis through modulating glial activation via SOCS3

Angiogenesis(2024)10.1007/s10456-024-09935-7Source: DataRank Database

Botulinum neurotoxin serotype A inhibited ocular angiogenesis through modulating glial activation via SOCS3 is a research paper published in Angiogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 0.40)OA: hybridTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Tianxi Wang ORCID,Manon Szczepan ORCID,Enton Lam,Hitomi Yagi ORCID,Katherine Neilsen

Live enrichment

PubMed:38922557 PMC:PMC11564384 OpenAlex:https://openalex.org/W4400039812

NIH/NEI

Grant: R01EY017017, R01EY030904, 1U54HD090255

NIH/NEI

Grant: R01EY030140, R01EY029238

NICHD NIH HHS

Grant: U54 HD090255

NICHD NIH HHS

Grant: P50 HD105351

NEI NIH HHS

Grant: R01 EY029238

NEI NIH HHS

Grant: R01 EY017017

NEI NIH HHS

Grant: R01 EY030140

NEI NIH HHS

Grant: R01 EY030904

National Institutes of Health

Grant: 5U54HD090255-05

Boston Intellectual and Developmental Disabilities Research Center

National Institutes of Health

Grant: 5R01EY030140-04

The Mechanism of Immune-Vascular Crosstalk in Retinopathy

National Institutes of Health

Grant: 5R01EY017017-05

Dietary control of angiogenesis in retinopathy model; basis for clinical trials

National Institutes of Health

Grant: 5R01EY030904-02

Glucose/lipid metabolism and vessel development in phase I ROP

National Institutes of Health

Grant: 1R01EY029238-01A1

Photoreceptor Determination of Retinal Blood Vessel Growth in Retinopathy

National Institutes of Health

Grant: 1R43EY013039-01

ANTI-ACANTHAMOEBA EYE INFECTION DROPS

Knights Templar Eye Foundation

BrightFocus Foundation

Massachusetts Lions Eye Research Fund

FWCI

0.40

Citation Percentile

0.6%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10456-024-09935-7.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10456-024-09935-7.pdf

publisherhttps://link.springer.com/article/10.1007/s10456-024-09935-7/fulltext.html

journalhttps://doi.org/10.1007/s10456-024-09935-7

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38922557

Fields of Study

Retinal Diseases and TreatmentsCerebral Venous Sinus ThrombosisPituitary Gland Disorders and Treatments0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsSuppressor of Cytokine Signaling 3 ProteinNeurogliaBotulinum Toxins, Type AChoroidal NeovascularizationMiceMice, Inbred C57BLVascular Endothelial Growth Factor AMice, KnockoutSuppressor of Cytokine Signaling ProteinsAngiogenesis

MeSH Terms

Suppressor of Cytokine Signaling 3 ProteinAngiogenesisAnimalsMice, Inbred C57BLNeurogliaMice, KnockoutBotulinum Toxins, Type AChoroidal NeovascularizationVascular Endothelial Growth Factor ASuppressor of Cytokine Signaling ProteinsMice

Keywords

Choroidal neovascularizationAngiogenesisVascular endothelial growth factorVascular endothelial growth factor APEDFBiologyCancer researchRetinaMacular degenerationMedicineNeuroscienceOphthalmologySOCS3Botulinum neurotoxin serotype AAge-related macular degenerationMicroglial ActivationGlial ActivationMüller ActivationMice, KnockoutOriginal PaperSuppressor of Cytokine Signaling ProteinsMice, Inbred C57BLMiceSuppressor of Cytokine Signaling 3 ProteinAnimalsBotulinum Toxins, Type ANeuroglia

Sustainable Development Goals

SDG 0: Good health and well-being

Botulinum neurotoxin serotype A inhibited ocular angiogenesis through modulating glial activation via SOCS3

FAIR Checklist

Authors (9)

Funding (17 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)